Concepedia

Li Lu

LL

Statistics

Publications

14

Citations

1.4K

H-Index

13

Active since

2005

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Chinese University of Hong Kong

Baylor College of Medicine

Chinese Academy of Sciences

Tongji Hospital

Li Lu is an author at The University of Texas MD Anderson Cancer Center specializing in life sciences, molecular biology, and hepatocyte proliferation.

ORCID

Publications per year

2005–2019

14

Publications

14

Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver

Li Lu, Ying Li, Soo Mi Kim et al. · Proceedings of the National Academy of Sciences · 2010 · 723 citations · Full text

, , +17

Hippo pathway coactivators Yap and Taz are required to coordinate mammalian liver regeneration

Li Lu, Milton J. Finegold, Randy L. Johnson · Experimental & Molecular Medicine · 2018 · 210 citations · Full text

, , +17

A Homeostatic Arid1a-Dependent Permissive Chromatin State Licenses Hepatocyte Responsiveness to Liver-Injury-Associated YAP Signaling

Weiping Li, Liguang Yang, Qiang He et al. · Cell stem cell · 2019 · 124 citations · Full text

, , +12

Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ

Jing Yi, Li Lu, Kilangsungla Yanger et al. · Hepatology · 2016 · 102 citations · Full text

, , +17

Cardiac Gene Activation Analysis in Mammalian Non-Myoblasic Cells by Nkx2-5, Tbx5, Gata4 and Myocd

Lei Zhou, Yu Liu, Li Lu et al. · PLoS ONE · 2012 · 42 citations · Full text

, , +13

1–5 of 14